We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.14% | 35.45 | 35.20 | 35.60 | 35.65 | 35.20 | 35.45 | 246,675 | 16:35:25 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.14 | 105.85M |
TIDMFUM
RNS Number : 4341C
Futura Medical PLC
30 September 2018
TR-1: Standard form for notification of major holdings
Hot Features
Premium
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)(i)
1a. Identity of the issuer or the
underlying issuer of existing shares Futura Medical plc
to which voting rights are attached(ii)
:
-------------------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
--------------------
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
--------------------
An acquisition or disposal of financial instruments
--------------------
An event changing the breakdown of voting rights
--------------------
Other (please specify)(iii) : Type 1 Disclosure as per the Transparency
Directive II Regulation
--------------------
3. Details of person subject to the notification obligation(iv)
Name Octopus Investments Nominees Limited
City and country of registered office
(if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
Name
-------------------------------------------------------------------
City and country of registered office
(if applicable)
-------------------------------------------------------------------
5. Date on which the threshold was
crossed or reached(vi) : 27/09/2018
-------------------------------------------------------------------
6. Date on which issuer notified 28/09/2018
(DD/MM/YYYY):
-------------------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer(vii)
of 8. A) (total of 8.B
1 + 8.B 2)
--------------------- --------------------- ---------------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 5.33% N/A 5.33% 121,006,002
--------------------- --------------------- ---------------------- --------------------
Position of
previous
notification
(if
applicable) 6.08% N/A 6.08%
--------------------- --------------------- ---------------------- --------------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
---------------------
GB0033278473 6,450,778 5.33%
-------------------- --------------------- -------------------------------------- ---------------------
SUBTOTAL 8. A 6,450,778 5.33%
------------------------------------------- -------------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting rights
financial date(x) Conversion rights that may be
instrument Period(xi) acquired if the instrument
is
exercised/converted.
-------------------- --------------------- -------------------------------------- ---------------------
SUBTOTAL 8. B 1
--------------------- -------------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to Art.
13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting rights
financial date(x) Conversion cash voting rights
instrument Period (xi) settlement(xii)
--------------------- --------------------- ---------------- --------------------
SUBTOTAL 8.B.2
---------------- --------------------
9. Information in relation to the person subject to the notification obligation
(please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by
any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the (underlying)
issuer
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity(xiv) (please add additional
rows as necessary)
Name(xv) % of voting rights % of voting Total of both if
if it equals or is rights it equals or is higher
higher than the notifiable through than the notifiable
threshold financial threshold
instruments if
it
equals or is
higher
than the
notifiable
threshold
------------------------------------------- ---------------- -------------------------------------------
Octopus
Capital Ltd
------------------------------------------- ---------------- -------------------------------------------
Octopus
Investments
Ltd
------------------------------------------- ---------------- -------------------------------------------
Octopus
Investments
Nominees Ltd 5.33%
------------------------------------------- ---------------- -------------------------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
-------------------------------------------------------------
The number and % of voting rights held
-------------------------------------------------------------
The date until which the voting rights
will be held
-------------------------------------------------------------
11. Additional information (N/A)
Place of completion 33 Holborn, London, EC1N 2HT
Date of completion 28/09/2018
-----------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLEAFNEDEPPEAF
(END) Dow Jones Newswires
October 01, 2018 02:00 ET (06:00 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
